ERVW-1 and cancer: Therefore, depending on the needs of the therapy and cancer model, VSV can be modified to narrow the tropism, or let the VSV-G protein maintain the broad tropism and modify the genome to insert antigens or additional surface proteins (normally between the G and L genes) to be used as potential cancer vaccines [125].